2016-03-11T00:00:00.000-05:00
clinical-stage biotechnology company,0.234611
immuno-oncology protein therapeutics,0.234611
product candidates,0.479308
Eastern Daylight Time,-0.264819
global pharmaceutical companies,0.479308
late preclinical development,0.479308
innovative therapeutics,0.212414
comprehensive discovery platform,0.493538
relevant extracellular protein,0.27479
R&D activities,0.326715
strategic collaborations,0.479308
